Rankings
▼
Calendar
NPCE FY 2021 Earnings — NeuroPace, Inc. Revenue & Financial Results | Market Cap Arena
NPCE
NeuroPace, Inc.
$482M
FY 2021 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$45M
+9.8% YoY
Gross Profit
$33M
74.0% margin
Operating Income
-$24M
-52.5% margin
Net Income
-$36M
-79.9% margin
EPS (Diluted)
$-2.17
Cash Flow
Operating Cash Flow
-$25M
Free Cash Flow
-$25M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$134M
Total Liabilities
$60M
Stockholders' Equity
$74M
Cash & Equivalents
$19M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$45M
$41M
+9.8%
Gross Profit
$33M
$30M
+10.4%
Operating Income
-$24M
-$13M
-81.9%
Net Income
-$36M
-$24M
-48.6%
← Q4 2020
All Quarters
Q1 2021 →